Editas Medicine Inc’s recently made public that its EVP, CHIEF SCIENTIFIC OFFICER Burkly Linda unloaded Company’s shares for reported $1535.0 on Dec 03 ’25. In the deal valued at $2.15 per share,713 shares were sold. As a result of this transaction, Burkly Linda now holds 68,777 shares worth roughly $0.14 million.
Then, O’Neill Gilmore Neil sold 5,603 shares, generating $12,064 in total proceeds. Upon selling the shares at $2.15, the CEO now owns 269,087 shares.
Before that, Parison Amy sold 461 shares. Editas Medicine Inc shares valued at $993 were divested by the SVP, Chief Financial Officer at a price of $2.15 per share. As a result of the transaction, Parison Amy now holds 15,908 shares, worth roughly $32452.32.
H.C. Wainwright initiated its Editas Medicine Inc [EDIT] rating to a Buy in a research note published on April 28, 2025; the price target was $3. A number of analysts have revised their coverage, including JP Morgan’s analysts, who decreased its forecast for the stock in mid December from “a Neutral” to “an Underweight”. Truist also remained covering EDIT and has decreased its forecast on December 13, 2024 with a “Hold” recommendation from previously “Buy” rating. Stifel revised its rating on December 13, 2024. It rated EDIT as “a Hold” which previously was an “a Buy”.
Price Performance Review of EDIT
On Tuesday, Editas Medicine Inc [NASDAQ:EDIT] saw its stock fall -2.86% to $2.04. Over the last five days, the stock has lost -12.45%. Editas Medicine Inc shares have risen nearly 65.85% since the year began. Nevertheless, the stocks have risen 60.63% over the past one year. While a 52-week high of $4.54 was reached on 10/08/25, a 52-week low of $0.91 was recorded on 04/07/25.
Levels Of Support And Resistance For EDIT Stock
The 24-hour chart illustrates a support level at 2.00, which if violated will result in even more drops to 1.95. On the upside, there is a resistance level at 2.11. A further resistance level may holdings at 2.17.
How much short interest is there in Editas Medicine Inc?
A steep rise in short interest was recorded in Editas Medicine Inc stocks on 2025-12-15, growing by 1.15 million shares to a total of 11.15 million shares. Yahoo Finance data shows the prior-month short interest on 2025-11-14 was 10.01 million shares. There was a rise of 10.29%, which implies that there is a positive sentiment for the stock.
